This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Martin D. Jaffe, MD; Park W. Willis III, MD

JAMA. 1965;193(2):158-160.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SODIUM HEPARIN, because of its anticoagulant and lipid-clearing effects, has gained widespread acceptance for the long-term treatment of coronary artery disease. Except for bleeding, usually the result of an excesssive therapeutic action, there have been few side effects reported. A previously unrecognized possible complication of heparin therapy is detailed here. A patient is presented in whom multiple fractures of vertebrae and ribs occurred in the last two months of a 13-month course of therapy with sodium heparin administered subcutaneously.

Report of a Case

A 41-year-old, married, white executive experienced angina pectoris in the summer of 1963 without clinically or electrocardiographically apparent myocardial infarction. Sodium heparin (Lipo-Hepin) therapy was started in October 1963. Each evening he received a single deep subcutaneous injection of 20,000 units (0.5 cc of 40,000 units/cc or approximately 200 mg) except for a 20-day period in August 1964, when he received approximately 280 mg nightly. The only . . . [Full Text PDF of this Article]

Author Affiliations
From General and Mercy hospitals, Bay City, Mich (Dr. Jaffe), and the Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor (Dr. Willis).

Footnotes
Reprint requests to 2110 16th St, Bay City, Mich 48708 (Dr. Jaffe).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?